245 filings
Page 4 of 13
8-K/A
ggb7k00v
18 Jul 22
Entry into a Material Definitive Agreement
5:10pm
PRE 14C
9ncddwf6j
15 Jul 22
Preliminary information
5:12pm
8-K
rhb 1yatxq
15 Jul 22
Entry into a Material Definitive Agreement
5:10pm
8-K
3if3ut88vg36gyj
29 Jun 22
Developing Transformative Therapies to Overcome Chronic Debilitating Diseases Corporate Presentation • June 2022
8:29am
8-K
7636or70 e8zu
1 Dec 21
Entry into a Material Definitive Agreement
9:15am
8-K
u55tou98sqj
14 Oct 21
Submission of Matters to a Vote of Security Holders
8:02am
S-8
h8uvnd
4 Oct 21
Registration of securities for employees
4:41pm
8-K
yjm93py7ois07
11 Aug 21
BioVie Inc. Announces Pricing of Public Offering of Common Stock
1:23pm
424B5
8uh zw4gqbx4g4b917ak
10 Aug 21
Prospectus supplement for primary offering
12:00am
FWP
ngzqkc9
6 Aug 21
Free writing prospectus
5:22pm
424B5
423wsb88rpkiamb30se
6 Aug 21
Prospectus supplement for primary offering
5:21pm
8-K
ow8k0
5 Aug 21
BioVie Announces First Patient Enrolled in Phase 3 Study of NE3107 in Alzheimer’s Disease
4:25pm
8-K
gucytbw 13mx
11 Jun 21
BioVie Announces Closing of Acquisition of BioPharma Assets from Privately Held NeurMedix
9:00am
DEFM14C
pfydu a7a9pg4gcy330
20 May 21
Information related to merger
4:47pm
8-K
0zwvc65uth
17 May 21
Regulation FD Disclosure
9:52am